肝病治疗行业之所以在中国被长期看好,主要原因还是因为西方国家这一领域新药开发速度不是很快。就本土企业,在不久的将来会有两个高发期:一是对于乙肝病毒的流行病学、基因组学、临床药学上都积累了较为丰富的经验,近几年可能是一批创新药品完成临床的高发期;二是企业层面也 The main reason why the treatment of liver diseases industry in China has long been optimistic is that the development of new drugs in the western countries is not very fast. In terms of local enterprises, there will be two periods of high incidence in the near future. One is that they have accumulated rich experience in the epidemiology, genomics and clinical pharmacy of hepatitis B virus. In recent years, they may have completed a number of innovative medicines The high incidence period; the second is the enterprise level also